MAM
ANIP icon

Meeder Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Meeder Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed – – 848
2022
Q3 		$0 Buy
3
+1
+50% +$34 ﹤0.01% 2133
2022
Q2 		$0 Sell
2
-16
-89% -$462 ﹤0.01% 2167
2022
Q1 		$1K Buy
+18
New +$671 ﹤0.01% 2136
2021
Q4 		– Sell
-1,392
Closed -$45K – 1190
2021
Q3 		$45K Buy
1,392
+1,369
+5,952% +$42.6K ﹤0.01% 1120
2021
Q2 		$1K Hold
23
– – ﹤0.01% 2302
2021
Q1 		$1K Sell
23
-4
-15% -$125 ﹤0.01% 2170
2020
Q4 		$1K Buy
27
+2
+8% +$57 ﹤0.01% 1587
2020
Q3 		$1K Buy
25
+23
+1,150% +$685 ﹤0.01% 1919
2020
Q2 		$0 Sell
2
-29
-94% -$1.04K ﹤0.01% 2037
2020
Q1 		$1K Sell
31
-1,969
-98% -$105K ﹤0.01% 2159
2019
Q4 		$125K Buy
2,000
+1,980
+9,900% +$131K 0.01% 732
2019
Q3 		$1K Sell
20
-2,548
-99% -$191K ﹤0.01% 2036
2019
Q2 		$211K Buy
+2,568
New +$183K 0.01% 566
2018
Q4 		– Sell
-7
Closed – – 1703
2018
Q3 		$0 Sell
7
-155
-96% -$9.48K ﹤0.01% 1527
2018
Q2 		$10.8K Sell
162
-3
-2% -$187 ﹤0.01% 1110
2018
Q1 		$10K Sell
165
-62
-27% -$3.94K ﹤0.01% 1054
2017
Q4 		$14K Buy
227
+200
+741% +$12.4K ﹤0.01% 1040
2017
Q3 		$1K Hold
27
– – ﹤0.01% 1532
2017
Q2 		$1K Buy
+27
New +$1.3K ﹤0.01% 1493

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Meeder Asset Management's ANIP Position: Q4 2022 in Review

Meeder Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2022, closing a stake of 3 shares.

Meeder Asset Management first reported a position in ANIP in Q2 2017 and held it in 19 quarters. The position peaked at $211K in Q2 2019. 125 funds tracked by Wall St. Rank hold ANIP as of Q4 2022.

  • Meeder Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 3 ANI Pharmaceuticals shares in Q4 2022.
  • Meeder Asset Management first reported a position in ANI Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • Meeder Asset Management's ANI Pharmaceuticals position peaked at $211K in Q2 2019.
  • 125 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.